Document Details
Form
Filing Date
Mar 16, 2022
Document Date
Mar 14, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
BioXcel Therapeutics
Issuer
BioXcel Therapeutics, Inc.